Opioids: Digital Apps
Due to the COVID-19 pandemic, the digital apps for opioid use disorder assessment will be paused now, to resume in 2-3 months.
ICER will assess the comparative clinical effectiveness and economic value of digital apps for opioid use disorder. ICER has reviewed other related topics, such as abuse-deterrent opioid formulations, medication-assisted treatment for opioid use disorder, and non-drug interventions for lower back pain.
This review reinforces ICER’s commitment to provide an independent evaluation of the evidence around interventions that target the public health crises stemming from the opioid epidemic in the United States.
Review date: November 2020
For more information, please contact Zunelly Odhiambo, Program Manager, at email@example.com.